INTRODUCTION
Angiogenesis is the formation of new blood vessels from existing ones through sprouting, proliferation, and migration of endothelial cells (ECs). In adult mammals, angiogenesis is an adaptive response to normal and pathophysiological conditions characterized by inadequate supply of oxygen and nutrients, ranging from tissue ischemia upon vessel occlusion or tumorigenesis to endurance exercise.
Hypoxia is the best-understood trigger of angiogenesis, stabilizing the oxygen-sensitive transcription factor hypoxia-inducible factor (HIF)1a in multiple cell types and promoting expression of the master regulator of angiogenesis, vascular endothelial growth factor (VEGF). VEGF expression can also be induced by the transcriptional co-activator PGC1a upon nutrient deprivation through an ERR-a-dependent, HIF1a-independent pathway in muscle cells but not ECs (Arany et al., 2008) , as well as by the ATF4 transcription factor downstream of the integrated stress response (ISR) triggered by either endoplasmic reticulum (ER) stress or amino acid (AA) deprivation (Abcouwer et al., 2002) .
VEGF acts on ECs via binding to the cell-surface tyrosine kinase receptor VEGFR2, triggering an orchestrated cascade of signal transduction via the PI3K and mitogen-activated protein kinase (MAPK) pathways involving critical second messengers nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) and changes in gene expression facilitating EC migration, proliferation, and vessel formation (Olsson et al., 2006) . VEGF-mediated angiogenesis is potentiated by the NAD+-dependent deacetylase SIRT1, which deacetylates and inactivates FOXO transcription factors (Potente et al., 2007) involved in negative regulation of EC migration and tube formation (Potente et al., 2005) . VEGF signaling also triggers changes in cellular energy metabolism-namely increased glucose uptake and glycolysis necessary to provide rapid energy for EC migration (De Bock et al., 2013) .
Hydrogen sulfide (H 2 S) is a proangiogenic gas (Cai et al., 2007; Szabó , 2007) produced in ECs upon VEGF stimulation (Papapetropoulos et al., 2009) primarily by the transsulfuration enzyme cystathionine-g-lyase (CGL, a.k.a. CTH or CSE) (Wang, 2012) . Like NO, which-in addition to activating cGMP synthesisfunctions through post-translational modification (S-nitrosylation) of target proteins (Fukumura et al., 2006) , H 2 S promotes angiogenesis through S-sulfhydration and activation of proximal signal transduction components, including VEGFR2 (Tao et al., 2013) and endothelial nitric oxide synthase (eNOS) (Altaany et al., 2014; Coletta et al., 2012) . Angiogenesis is compromised upon genetic CGL deficiency in aorta explant assays ex vivo (Papapetropoulos et al., 2009) and arterial ligation in vivo (Kolluru et al., 2015) . However, mechanisms of CGL regulation in ECs and the relative contribution of H 2 S versus NO in angiogenesis remain unclear (Katsouda et al., 2016) .
Dietary restriction (DR), defined as reduced nutrient/energy intake without malnutrition, is best known for its ability to extend lifespan, improve metabolic fitness, and increase stress resistance (Colman et al., 2009; Fontana et al., 2010; Hine et al., 2015) . DR regimens, which vary widely, can emphasize either restriction of total food intake (calorie restriction, CR) or dilution of specific nutrients in the diet, such as the sulfur AAs (SAAs) methionine (M) and cysteine (C) (M restriction, MR) (Miller et al., 2005; Orentreich et al., 1993) . We recently reported that CR increases hepatic CGL expression, endogenous H 2 S production capacity, and resistance to hepatic ischemia reperfusion injury, each of which is abrogated by dietary C supplementation (Hine et al., 2015) . CR also promotes revascularization and recovery from femoral artery ligation in rodents (Kondo et al., 2009) and maintains vascular health in rodents and non-human primates in part by preserving capillary density in skeletal muscle (Omodei and Fontana, 2011) . Interestingly, SIRT1 is activated in some tissues upon DR (Cantó and Auwerx, 2009; Wang, 2014) and required for VEGF-dependent angiogenesis (Potente et al., 2007) . However, the effects of DR on angiogenesis and the potential role of H 2 S remain unknown. Here, we identified SAA restriction as a proangiogenic trigger in ECs in vitro and in skeletal muscle in mice in vivo.
RESULTS

SAA Restriction Induces Endothelial VEGF Expression In Vitro and Functional Angiogenesis In Vivo
We tested the potential of isolated nutrient restriction independent of ischemia or hypoxia to impact angiogenesis in vitro using a model of SAA restriction (Hine et al., 2015) . Human umbilical vein ECs (HUVECs) cultured overnight in media lacking SAAs (ÀM&C) displayed increased VEGF mRNA expression and protein secretion into the media (Figure 1A) . This correlated with increased proangiogenic potential, including migration across a scratch (Figure 1B) , formation of capillary-like structures (tube formation; Figure 1C ), and increased sprout length in three-dimensional HUVEC spheroid cultures-an effect that was abrogated by the specific VEGFR2 inhibitor SU5416 (Figure 1D) . Inhibiting SIRT1 activity with Ex-527 significantly reduced HUVEC tube formation (Figure 1C) and branch point number ( Figure S1A ) upon ÀM&C, suggesting that the proangiogenic pathway triggered by ÀM&C is dependent on both VEGF and SIRT1 activity.
To test the impact of dietary SAA restriction on angiogenesis in vivo, mice were given ad libitum access to an MR diet containing a limiting amount of M and lacking C (Miller et al., 2005; Orentreich et al., 1993) . Young adult wild-type (WT) mice on MR for up to 2 months maintained a lower body weight despite normal food intake relative to mice fed a control diet containing normal M and C levels ( Figure S1B ).
Strikingly, MR resulted in increased vascular density in skeletal muscle as determined by immunohistochemistry (IHC) (Figure 1E) and flow cytometric analysis (Figure S1C ) for the EC marker CD31. Consistent with VEGF dependence, this effect was blocked by axitinib, one of the best-characterized VEGF receptor inhibitors in vivo with demonstrated antiangiogenic activity in the context of tumor neovascularization (Ma and Waxman, 2008) (Figures 1E and S1C) . Interestingly, although expression of VEGF mRNA was not consistently affected upon MR in whole gastrocnemius muscle (Figure S1D) , there was a trend toward increased VEGF protein in gastrocnemius muscle extracts (Figure S1E) . VEGF and CD31 co-localized in gastrocnemius muscle by IHC (Figure S1F) , consistent with ECs as the source of VEGF upon MR in vivo as observed upon ÀM&C in vitro (Figure 1A ).
Functional significance was tested in the context of femoral artery ligation in mice preconditioned on MR or control diet for 1 month prior to surgical occlusion and returned to a complete diet after surgery (Figure S1G) . Although blood flow was similarly interrupted in both diet groups immediately after ligation (d0), return of blood flow indicative of neovascularization was accelerated in MR mice, with significant improvement by d3 after ligation ( Figure 1F ). CD31 IHC of muscle sections confirmed a relative increase in capillary density in both ischemic and non-ischemic legs of MR versus control mice despite a return to a complete diet for 10 days ( Figure 1G ). Functional improvement was also observed in mice preconditioned on a different DR regimen-40% CR-for 1 month prior to femoral ligation (Figures S1H and S1I) . In addition to improved return of blood flow (Figure S1H) , CR mice demonstrated improved treadmill exercise endurance testing on d4 after ligation ( Figure S1I ). Together, these data suggest neovascularization induced by DR (in the form of CR or MR) as a contributing factor in the improved physiological response to acute blood flow cessation.
GCN2-Dependent, Hypoxia-Independent Regulation of VEGF and Angiogenesis upon SAA Restriction Although HIF1a upon hypoxia is the best-characterized trigger of VEGF expression in multiple cell types, including ECs, increased VEGF expression upon ÀM&C was unaffected by HIF1a RNAi knockdown (KD) (Figures 2A and S2A ) and coincided with a trend toward reduced HIF1a protein expression (Figures 2B and S2B) . PGC1a can also induce VEGF independently of HIF1a upon total nutrient/growth-factor deprivation in myocytes but not ECs (Arany et al., 2008) . Consistent with this, endogenous PGC1a mRNA expression in HUVECs was very low as judged by Ct value (data not shown) and unaffected by ÀM&C (Figure S2C ), while exogenous PGC1a overexpression in HUVECs failed to modulate VEGF expression ( Figures S2D and S2E) .
The AA starvation response (AASR), a branch of the ISR involving binding of uncharged cognate tRNAs to the general control nonderepressible 2 (GCN2) kinase, phosphorylation of eukaryotic translation initiation factor 2a (eIF2a), and translational derepression of ATF4 (Kilberg et al., 2005; Wek et al., 1995) , has been implicated in DR-mediated resistance to ischemia reperfusion injury (Peng et al., 2012) but has not been assessed in ECs. In HUVECs, ÀM&C increased eIF2a phosphorylation, ATF4 protein expression, and transcription of the ATF4 target, Asns ( Figures  2B, S2B , and S2F). ATF4 small interfering RNA (siRNA) reduced (A) VEGF mRNA levels (left, n = 4 experiments per group) and secreted protein concentration in the media (right, n = 6 experiments per group) of HUVECs cultured in control (Ctrl) or SAA-deficient (ÀM&C) media for 16 hr. Error bars indicate SEM. (B) Migration assay: representative migration across a scratch (left, 103 magnification at t = 20 hr; dotted lines indicate boundary of the scratch at t = 0 hr) and area under the curve (AUC; right, n = 7-10 data points per condition, with each data point representing the mean of multiple measures within a single well in a representative experiment) from HUVECs cultured in the indicated media. (C) Tube formation assay: representative capillary-like structures (left, 403 magnification) and quantification of tube length/field in arbitrary units (AU; right, n = 8-10 data points per condition) in HUVECs incubated in the indicated media ± SIRT1 inhibitor Ex-527 for 18 hr. (D) Spheroid assay: representative images (left, 403 magnification) and quantification (right, in triplicate) of sprouting HUVEC spheroids in the indicated media ± VEGFR2 inhibitor SU5416 for 24 hr. Blue, DNA (DAPI); red, F-actin (phalloidin) . (E) Representative transverse sections (left, 403 magnification) and quantification (right) of gastrocnemius muscle stained for endothelial marker CD31 in mice fed for 2 weeks on control or MR diet ± VEGFR2 inhibitor axitinib; n = 6-8 mice per group. (F) Longitudinal Doppler imaging of blood flow in WT mice preconditioned for 1 month on control or MR diet prior to femoral artery ligation (I, ischemic; NI, nonischemic) . Representative infrared images on the indicated day after ligation (left). Quantification of blood flow recovery with individual animal AUCs used for statistical comparison (right, n = 7-8 mice per group). (G) Representative transverse sections (left, 403 magnification) and quantification (right) of CD31-stained gastrocnemius muscle 10 days after ligation from (F) ; n = 4 mice per group. Error bars indicate SD unless otherwise noted; asterisks indicate the significance of the difference by Student's t test or one-way ANOVA with Sidak's multiple comparisons test between diets in vivo or SAA deprivation in vitro; *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S1 .
VEGF and Asns transcriptional upregulation upon ÀM&C ( Figures  2C and S2F ), while ATF4 overexpression increased VEGF and Asns mRNA expression and VEGF secretion into the media ( Figure 2E ) independent of nutrient deprivation.
The requirement for GCN2 was tested in primary ECs isolated from WT ( Figure S2J ) and GCN2 knockout (GCN2KO) mice. Similar to HUVECs, -M&C significantly increased VEGF and Asns mRNA expression (Figures 2F and S2K) and sprout length (Figure 2G ) in WT but not GCN2KO ECs. In vivo, GCN2KO mice failed to increase vascular density upon 2-4 weeks of MR compared to controls (Figure 2H) .
ÀM&C also increased VEGF mRNA expression in primary mouse dermal fibroblasts (MDFs), immortalized mouse embryonic fibroblasts (MEFs) and C2C12 myotubes ( Figure 2I ). In primary skeletal myotubes, VEGF induction upon ÀM&C required (E, n = 3-6 experiments per group; SEM) 2 days after transfection with ATF4 overexpression (ATF4 OE ) or control construct (Empty).
(F and G) VEGF mRNA expression (F) and spheroid formation (G) Figure S2 . GCN2 ( Figure 2J ). In MDFs, ATF4 short hairpin RNA (shRNA) prevented the increase in VEGF mRNA by ÀM&C ( Figure S2L ). In C2C12 myotubes, VEGF induction coincided with increased eIF2a phosphorylation and ATF4 expression and reduced HIF1a protein levels ( Figure 2K ). Notably, VEGF induction upon ÀM&C in C2C12 myotubes was unaffected by HIF1a RNAi KD under normoxic (20%) or hypoxic (<1%) oxygen tensions ( Figures S2M-S2O ). PGC1a RNAi KD also failed to dampen VEGF induction upon ÀM&C in C2C12 myotubes ( Figure S2P ). Taken together, these data reveal SAA restriction and the GCN2/ATF4-dependent AASR as a novel trigger of increased VEGF expression and angiogenesis independent of hypoxia, HIF1a, or PGC1a.
VEGF Signaling and AASR Converge on Endothelial H 2 S Production by CGL VEGF promotes angiogenesis in part by stimulating CGL-dependent production of the proangiogenic gas H 2 S in ECs (Papapetropoulos et al., 2009); however, mechanisms of CGL regulation in ECs and the importance of H 2 S in angiogenesis remain poorly understood. H 2 S production capacity ( Figure 3A) and endogenous H 2 S levels ( Figure 3B ) were similarly increased by ÀM&C and exogenous VEGF addition and were sensitive to the CGL inhibitor propargylglycine (PAG). ÀM&C also boosted endogenous H 2 S production in primary hepatocytes, while VEGF did not, because hepatocytes lack VEGFR2 ( Figure S3A ).
CGL is an ATF4 target downstream of the ISR triggered either by ER stress in MEFs (Dickhout et al., 2012) or C deprivation in HepG2 cells (Lee et al., 2008) . In primary mouse ECs, CGL mRNA was strongly induced upon ÀM&C ( Figure 3C ). This effect was abrogated in ECs lacking GCN2 ( Figure 3C ) or in HUVECs upon ATF4 KD ( Figures 3D and S2F ), while ATF4 overexpression increased CGL independent of SAA deprivation ( Figure 3E ). Importantly, VEGF mRNA was not affected by the absence of CGL ( Figure S3B ) in vitro, consistent with CGL and VEGF as independent downstream targets of the AASR. Interestingly, exogenous VEGF increased CGL mRNA ( Figure S3C ) and protein ( Figure S3D ) expression in HUVECs independent of nutrient deprivation, suggestive of a positive feedback loop between VEGF and CGL expression, but without affecting expression of the two other H 2 S-generating enzymes, CBS or 3-MST. The functional relevance of endothelial CGL in angiogenic potential in vitro was assessed in the EC spheroid assay. Increased sprout length of EC spheroids upon ÀM&C was prevented by the CGL inhibitor PAG in HUVEC ( Figure 3F ) and in CGL knockout (CGLKO) mouse ECs ( Figure 3G ). Thus, CGL is required for angiogenesis induced by ÀM&C in vitro.
CGL Required for Angiogenesis In Vivo
We next tested the requirement for CGL-derived H 2 S in angiogenesis triggered by MR in vivo. Consistent with CGL as the major H 2 S producer in EC in vivo (Wang, 2012) , P3 fluorescence indicative of endogenous H 2 S production co-localized with CD31 + cells in fresh-frozen sections of gastrocnemius muscle from WT but not CGLKO mice ( Figure 4A ). Quantification of P3 intensity in WT and CGLKO mice fed control versus MR diet for 2 weeks confirmed a CGL-dependent increase in EC H 2 S production upon MR in vivo (Figure 4B) . Coincident with failure to increase H 2 S, CGLKO mice failed to increase capillary density upon MR in vivo relative to WT mice ( Figure 4C ). Furthermore, the CGL inhibitor PAG partially prevented 40% CR from improving recovery from femoral ligation (Figures S1H and S1I) . Taken together, these data are consistent with a requirement for CGL-derived H 2 S for angiogenesis triggered by nutrient deprivation. We next asked if CGL-derived H 2 S is sufficient to promote angiogenesis independent of SAA restriction. To this end, we injected CGL-expressing adenovirus into the gastrocnemius muscle of WT mice via intra-muscular injection, likely resulting in CGL overexpression in both myotubes and ECs due to the ability of the Ad5 serotype to infect multiple cell types. Local CGL viral transduction increased muscle H 2 S production capacity (Figure S4A ) and vascular density ( Figure 4D ) independent of any other proangiogenic stimulus, suggesting that an increase in CGL-derived H 2 S is sufficient to trigger angiogenesis.
To test this apparent general requirement for CGL in angiogenesis independent of the upstream stimulus, we induced angiogenesis by either treadmill exercise training or by VEGF overexpression via intra-muscular injection of VEGF-overexpressing (ad-VEGF 165 ) adenovirus. Exercise training increased endogenous VEGF mRNA expression in WT mice ( Figure S4B ), while both exercise training ( Figure 4E ) and local VEGF overexpression via adenoviral gene delivery ( Figure 4F ) increased capillary density in WT but not CGLKO mice. Taken together, these data indicate that CGL is necessary for VEGF-mediated neovascularization in vivo independent of the upstream proangiogenic stimulus.
H 2 S Promotes Glucose Uptake and ATP Generation by Glycolysis for EC Migration
Because CGL is a promiscuous enzyme that can convert cystathionine to C as part of the transsulfuration pathway (TSP) but can also use C to produce H 2 S and serine, we sought more direct evidence of H 2 S as the CGL metabolite relevant to angiogenesis. H 2 S addition to standard EC media in the form of NaHS increased proliferation ( Figure S5A ) and migration across a scratch ( Figure 5A ). This latter effect was only partially blocked with mitomycinC (MitoC), consistent with migration as a critical factor in H 2 S-induced proangiogenic potential. In support of this, HUVECs overexpressing CGL (Ad-CGL) formed lamellipodial projections over larger areas ( Figure 5B ) coincident with increased migration speed and greater cell body displacement ( Figure 5C ). Cell migration requires rapid ATP generation to facilitate actin cytoskeleton rearrangement, which in ECs is met by increasing glycolytic metabolism (De Bock et al., 2013; Schoors et al., 2014) . We thus examined glucose uptake and glycolytic ATP production as a function of genetic and pharmacological H 2 S modulation. Treatment for 30 min with NaHS increased glucose uptake in HUVECs similar to VEGF ( Figure 5D ). Interestingly, H 2 S-induced glucose uptake was independent of SIRT1 in mouse ECs ( Figure S5B ).
Glycolytic activity was assessed using several methods. Extracellular acidification rate (ECAR), a surrogate marker of glycolysis, was increased by NaHS treatment in HUVECs (Figure S5C) . In primary ECs from WT mice, NaHS and VEGF increased ECAR to a similar level (Figures 5E and S5D) , while in CGLKO ECs, ECAR was significantly reduced at baseline and increased by NaHS but not VEGF administration (Figure 5E) . Interestingly, accumulation of the end product of aerobic glycolysis, lactate, in the media following NaHS treatment did not reach the level of statistical significance ( Figure S5E ). We thus measured glycolysis directly using the release of 3 H 2 O from C5-3 H-glucose and found a significant increase upon NaHS or VEGF treatment ( Figure 5F ) beginning after 30 min ( Figure S5F ). Consistent with increased glycolysis, H 2 S boosted intracellular ATP levels over a rapid time course similar to exogenous VEGF ( Figure 5G ). Both exogenous H 2 S addition and CGL overexpression also increased EC migration, and this was sensitive to competitive inhibition of glycolysis by 2-deoxy-D-glucose (2-DG; Figures 5H and 5I ). Together, these data support the functional relevance of CGL-derived H 2 S in activation of glycolytic ATP generation necessary for proangiogenic migratory behavior.
Steady-state flux analysis was employed to better understand glucose disposal upon NaHS treatment. Addition of 13 C1,2-glucose to the media for the final 15 min of a 2-hr NaHS treatment revealed significant changes in labeling of glycolytic intermediates, including an increase in glyceraldehyde-3-phosphate, dihydroxy-acetone-phosphate, and fructose-phosphate ( Figure 5J ). Interestingly, a significant increase was also observed in the pentose phosphate pathway (PPP) and purine biosynthetic intermediates, including sedoheptulose-7P, phosphoribosyl-1-pyrophosphate, and inosine monophosphate (IMP) ( Figure 5J ). A significant increase in total unlabelled glycolytic and nucleotide metabolites was also observed ( Figure S5G ). Increased glucose flux through the PPP is required for angiogenesis (Bierhansl et al., 2017; Vizá n et al., 2009) and could also contribute to increased ECAR via CO 2 release during the oxidative phase of the reaction (Figures 5E and S5C) but is not mutually exclusive with the observed increase in glycolytic ATP generation. Finally, we asked if NaHS and M&C removal triggered similar metabolic responses as predicted if endogenous H 2 S production upon ÀM&C is important for its proangiogenic action. To this end, we performed unbiased metabolomic analyses of HUVECs cultured under standardized media conditions (complete DMEM supplemented with dialyzed fetal bovine syndrome [FBS] and EC growth factors) for 1 hr before addition of NaHS or M&C removal. A comparison of global profiles over a time course following treatment revealed a time-dependent shift upon ÀM&C away from the control and a striking convergence after 4 hr with the 15-min NaHS profile ( Figure 5K ). An analysis of all significant changes in the same direction between the 15-min NaHS and ÀM&C groups included glycolytic and PPP intermediates ( Figure 5L ).
H 2 S Shifts Oxidative/Glycolytic Balance Concomitant with Inhibition of Mitochondrial OXPHOS
By what mechanism does H 2 S promote glucose uptake and disposal in ECs? Increased ECAR by NaHS was unaffected by axitinib or the eNOS competitive antagonist L-nitroarginine methyl ester (L-NAME) ( Figure S5H ). Similarly, NaHS-induced EC migration was unaffected by L-NAME ( Figure S5I ) or genetic eNOS KD ( Figures S5J and S5K ), together suggesting a mechanism of action either independent or downstream of proximal VEGFR2 signaling.
In many cell types, inhibition of mitochondrial oxidative phosphorylation (OXPHOS) and transient ATP depletion initiates adaptive responses, including AMP-activated protein kinase (AMPK) activation, that boost glucose uptake and glycolytic ATP production (Hardie et al., 2016) . At high concentrations, H 2 S can inhibit complex IV of the mitochondrial electron transport chain (ETC) and prevent ATP generation by OXPHOS (Smith et al., 1977) ; however, whether this mechanism of action contributes to its proangiogenic effect is unknown. Despite the fact that ECs rely predominantly on glycolysis (De Bock et al., 2013) , we observed significant changes in glucose flux through the citric acid cycle (reduced citrate/isocitrate and oxaloacetate; Figure 5J) , as well as reduced total citrate (Figure S5G) , suggesting a block in mitochondrial OXPHOS without an increase in cell death ( Figure S5L ). Interestingly, labeled and total malate were increased in the same analyses, possibly due to an increase in the cytoplasmic pool, which cannot be distinguished from the mitochondrial pool in whole-cell lysates.
CGLKO ECs displayed increased oxygen consumption rate (OCR) under basal conditions relative to WT cells (Figure 6A) , consistent with the ability of endogenous H 2 S to inhibit mitochondrial ETC activity. Similarly, exogenous H 2 S decreased OCR concomitant with an increase in ECAR to the same levels as the complex V inhibitor oligomycin (Figure 6B ). To confirm the predicted effects of H 2 S on complex IV activity, OCR was (A) Representative migration across scratch (left, 103 magnification) and quantification (right) of HUVECs ± 100 mM NaHS in the presence of vehicle or mitomycin C (MitoC, 1 mg/mL) to inhibit proliferation. n = 12 wells each from cells at two different passages; one-way ANOVA with Sidak's multiple comparisons test between control and NaHS within vehicle or MitoC treatment group. (B and C) Representative images (B) and quantification (C) of migration speed (left, n = 5-7 cells per condition) and distance (right, n = 5-7 cells per condition in x and y directions) from time-lapse video imaging of GFP+ HUVECs infected with control (Ad-null) or CGL adenovirus (Ad-CGL) as indicated; Student's t test. (D) Relative glucose uptake in HUVECs pretreated with NaHS or 50 ng/mL VEGF for 1 hr. n = 3-6 experiments per group; one-way ANOVA with Dunnett's multiple comparisons test. Error bars indicate SEM. (E) ECAR in WT and CGLKO primary mouse ECs pretreated for 1 hr with VEGF or NaHS. 10 technical replicates from ECs pooled from six mice per genotype; one-way ANOVA with Sidak's multiple comparisons test as indicated. (F) Glycolytic flux in HUVECs pretreated for 3 hr with NaHS or VEGF. Representative experiment of six with n = 3 per group; one-way ANOVA with Dunnett's multiple comparisons test. (G) Time-dependent ATP production in HUVECs pretreated with NaHS or 1 mM 2-DG at t = 0. n = 4 experiments each for NaHS and VEGF and 2 for 2-DG; error bars indicate SEM; two-way ANOVA with Dunnett's multiple comparisons test relative to t = 0 (asterisk, NaHS; caret, VEGF; pound sign, 2-DG). (H and I) Representative migration (left, 103 magnification) and quantification (right, AUC) of HUVECs treated ± NaHS (H, n = 11 technical replicates per condition) or infected with a control (Ad-null) or CGL adenovirus (Ad-CGL) at a multiplicity of infection of 50 (I, n = 5-6 technical replicates per condition) in the presence of vehicle or 2-DG; one-way ANOVA with Sidak's multiple comparisons test between control and NaHS or Ad-Null and Ad-CGL within 2-DG or vehicle treatment group. (J) Log2 fold change of C13-labeled metabolites in HUVECs measured by mass spectrometry after 1 hr of NaHS pretreatment compared to control. Red dots, metabolites with false discover rate (FDR) adjusted p < 0.05 and absolute value of log2 fold change >1.2; blue dots, metabolites with FDR adjusted p > 0.05 and/or absolute value of log2 fold change <1.2. (K) Plot of the first two components of orthogonal partial least squares discriminant analysis on unlabeled metabolite levels in HUVECs after 15-min, 2-hr, or 4-hr treatment with NaHS or ÀM&C. Ellipses represent 99% confidence bound for treatment groups. measured in isolated HUVEC mitochondria in the presence of NaHS or the complex IV inhibitor potassium cyanide (KCN). In addition to the expected decrease in OCR in the presence of the complex IV substrate TMPD-ascorbate, NaHS also reduced oxygen consumption fueled by pyruvate, consistent with additional ETC inhibition at complex I ( Figure 6C ). We next asked if complex IV inhibition was sufficient to trigger AMPK activation in ECs. AMPK was activated within 5 min of NaHS or KCN treatment ( Figures 6D and 6E ) and returned to baseline after 30 min. Treatment with an AMPK inhibitor (compound C) prevented the increase in ECAR (Figure 6F ), glucose uptake, and migration ( Figures S6A and S6B) . Consistent with the rapid and transient nature of AMPK activation, 10-min NaHS treatment was sufficient to promote EC migration during the subsequent 12-hr period, and this was blocked by compound C (Figures S6C and S6D) .
To determine if energy stress was the proximal trigger to AMPK activation, we measured ATP/ADP ratio over a time course following NaHS addition, as well as energy charge 15 min after NaHS addition, but observed no significant changes ( Figures S6E and S6F) . AMPK can also be activated by upstream kinases, such as CamKKb (Lee et al., 2012) , or reactive oxygen species (ROS) upon hypoxia (Emerling et al., 2009) or nutrient/ energy deprivation (Li et al., 2013) . However, NaHS-mediated glucose uptake was unaffected by the CamKKb inhibitor STO-609 ( Figure S6G ), while mitochondrial ROS failed to increase upon NaHS or KCN treatment ( Figure S6H) .
Nonetheless, if inhibition of mitochondrial ATP synthesis is the trigger by which H 2 S promotes AMPK activation, glycolytic ATP production, and angiogenesis, then any ETC inhibitor could have similar proangiogenic effects. Consistent with this hypothesis, multiple ETC inhibitors targeting different complexes, as well as the uncoupler FCCP, increased glucose uptake (Figure 6G) , albeit with slightly different kinetics ( Figure S6I ). ECAR ( Figures  6H and S6J ) and glycolytic flux ( Figure S6K) were also stimulated by OXPHOS inhibition. Finally, multiple ETC inhibitors stimulated 2-DG-sensitive EC migration ( Figures 6I and S6L) . Together, these data are consistent with a mechanism of H 2 S action in angiogenesis involving transient inhibition of mitochondrial respiration by direct inhibition of ETC, resulting in increased glucose uptake and a shift from OXPHOS to glycolysis and PPP.
DISCUSSION
SAA Restriction as a Proangiogenic Trigger
A model for the proangiogenic pathway activated by SAA restriction and controlled by the GCN2-/ATF4-dependent AASR independent of hypoxia, HIF1a, or PGC1a in ECs is presented in Figure 7 . While ATF4 regulation of VEGF expression has been reported in the context of the ISR activated by AA deprivation or ER stress in a human retinal pigmented EC line in vitro (Abcouwer et al., 2002) or by mutation of tRNA synthetase genes in zebrafish in vivo (Castranova et al., 2016) , it has not been previously linked to SAA deprivation via GCN2 in ECs. ATF4 can also activate CGL and H 2 S production, which can feed back to increase eIF2a phosphorylation and further activate the ISR (Yadav et al., 2017) . Future studies will be required to determine the impact of AA deprivation on other proangiogenic factors, such as fibroblast growth factor (FGF), and if there is any specificity to SAAs. Furthermore, while ATF4 can activate VEGF and CGL expression in multiple different primary cell types in vitro, it remains to be determined which cell types in vivo are critical for the proangiogenic effects of SAA restriction.
Although H 2 S can also be generated by other enzymes, including CBS or 3-MST, we found a genetic requirement for CGL in angiogenesis triggered by nutrient deprivation, exercise, or VEGF injection (Figure 4) . CGL is also critical for de novo C biogenesis via TSP, linking M cycle metabolites upstream to glutathione and taurine production downstream, perturbation of any of which could potentially contribute to the observed effects. Finally, we acknowledge the apparent paradox of increased endogenous H 2 S production in response to restriction of its substrate, C. However, as the source of free C for H 2 S generation by CGL is not currently known, it could come from pools distinct from dietderived or de novo-produced C. For example, cytoplasmic glutathione levels that are in the mM range could be utilized as a source of free C, as could products of proteosomal protein degradation or lysosomal autophagy. In support of this latter notion, the increase in H 2 S production induced by growth factor (serum) withdrawal in cultured cells is partially abrogated by genetic or pharmacological inhibition of autophagy (Hine et al., 2017) , while the benefits of MR on longevity in yeast require autophagy (Ruckenstuhl et al., 2014) . In an accompanying manuscript, Das et al. (2018) report an interaction between H 2 S and SIRT1 in the regulation of angiogenesis as evidenced by the ability of H 2 S/NMN supplementation in old mice to reverse age-associated loss of muscle vascular density and improved exercise performance. Although the mechanism by which H 2 S augments SIRT1 function remains to be elucidated, these data suggest that H 2 S and SIRT1 function in a critical axis regulating angiogenesis with the potential to mitigate or reverse oxidative stress-induced and aging-related changes in vascular health using pharmacological agents.
Mechanisms of H 2 S Regulation of Energy Metabolism in ECs
H 2 S at physiological levels is thought to exert its biological activities through non-mutually exclusive mechanisms, including post-translational modification of target proteins via S-sulfhydration of surface-exposed C residues (Mishanina et al., 2015; Mustafa et al., 2009) , direct or indirect antioxidant action (Whiteman et al., 2004; Whiteman et al., 2005) , or ATP generation via transfer of electrons to the mitochondrial SQR protein (Goubern et al., 2007; Yong and Searcy, 2001 ). There is clearly precedent for the potential of H 2 S to regulate angiogenesis via S-sulfhydration of target proteins in multiple pathways implicated in angiogenesis, ranging from VEGFR2 signaling (Altaany et al., 2014; Coletta et al., 2012; Tao et al., 2013 ) to cellular energy metabolism via activation of the rate-limiting glycolytic enzyme GAPDH (Mustafa et al., 2009) .
H 2 S can also inhibit terminal electron transfer to oxygen (Nicholls and Kim, 1982) at supraphysiological levels, estimated to be greater than 20 mM upon acute treatment of intact human colon carcinoma ECs (Leschelle et al., 2005) . Our data are consistent with the potential relevance of this mechanism in regulation of EC oxidative/glycolytic energy balance, although whether levels of endogenously generated H 2 S upon SAA deprivation here or in other contexts reach this inhibitory concentration remains unclear (Cooper and Brown, 2008) . Consistent with our findings in ECs, an increase in H 2 S in pancreatic b cells exposed to ER stress promotes aerobic glycolysis associated with decreased OXPHOS and increased S-sulfhydration of enzymes involved in energy metabolism (Gao et al., 2015) . Interestingly, a number of tumors and cancer cells lines also upregulate GCN2 (Lehman et al., 2015; Wang et al., 2013) or H 2 S production (Bhattacharyya et al., 2013; Sen et al., 2015; Sonke et al., 2015; Szabo et al., 2013) , possibly contributing to the Warburg effect through inhibition of mitochondrial respiration.
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Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
All experiments were performed with the approval of the Harvard Medical Area or Boston University Institutional Animal Care and Use Committee (IACUC). 8-14 week old male or female C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) were used for all experiments unless otherwise indicated. Male and female CGL WT and KO mice on a mixed 129/C57BL/6 background (Yang et al., 2008) and GCN2KO and control mice on a C57BL/6 background (Peng et al., 2012) were bred at our facility. Except where indicated, animals were maintained under standard group housing conditions with ad libitum (AL) access to food (Purina 5058) and water, 12-hr light/12-hr dark cycles, temperature between 20-23 C with 30%-70% relative humidity. Experimental diets were based on Research Diets D12450B with approximately 18% of calories from protein (hydrolyzed casein or individual crystalline amino acids (Ajinomoto) in the proportions present in casein), 10% from fat and 72% from carbohydrate. MR diets containing 1.5g methionine (M)/kg food and lacking cysteine (C) (Miller et al., 2005) in the context of a 14% protein/ 76% carbohydrate calorie diet were provided AL. In MR experiments with WT and CGLKO mice, the control diet was supplemented with 4.3g C/kg food to compensate for the inability of CGLKO mice to make C. AL food intake/g body weight was monitored daily for several days and used to calculate calorie restriction (CR) based on initial animal weights. Animals were fed daily with fresh food between 6-7 PM.
Where indicated, axitinib was supplemented at a daily dose of $30 mg/kg/d in the food as previously described (Alonso et al., 2010; Ma and Waxman, 2008) ; and PAG was dosed once daily i.p. (10 mg/kg) for the indicated time.
Cell Lines and Primary Tissue Culture Studies
Pooled human umbilical vein endothelial cells (HUVECs) were obtained from Lonza (C2519A, Lonza) and used between passage 1 and 7. HUVECs were cultured in endothelial basal medium (EBM-2) supplemented with 2% FBS and endothelial growth medium SingleQuots (Clonetics, Lonza) at 37 C in a humidified, multigas incubator (Napco Series 8000 WJ, Thermo Scientific) at 5% CO 2 and 3% O 2 achieved by displacing air with nitrogen gas. Primary mouse endothelial cells were isolated from the lung by collagenase digestion (Liberase, Roche) followed by sequential affinity selection using Dynabeads goat anti-rat conjugated to rat-anti mouse CD31 (BD Biosciences, San Jose, CA), and cultured in endothelial basal medium (EBM-2) supplemented with 2% FBS and endothelial growth medium SingleQuots (Clonetics, Lonza) at 37 C, 5% CO 2 and 3% O 2 . At least 3 independent primary mouse EC cultures/genotype was tested per experiment. Primary mouse hepatocytes were isolated by collagenase digestion, Percoll (GE Healthcare) gradient centrifugation and cultured in William's E media (Sigma) with 5% FBS at 37 C, 5% CO 2 and 3% O 2 . Primary mouse dermal fibroblasts (MDFs) were obtained from tail skin of WT mice following collagenase digestion and cultured in DMEM with 10% FBS at 37 C, 5% CO 2 and 3% O 2 . Primary mouse skeletal myotubes were isolated from leg skeletal muscle following collagenase/dispase digestion and cultured in Ham's F12 with 20% FBS and 10 ng/mL bFGF for approximately one week, then switched to Ham's F12 supplemented with 4% horse serum but lacking bFGF for 7 days at 37 C in 5% CO 2 at normoxia (20% O 2 ). C2C12 myoblasts were cultured in DMEM with 10% FBS until they reached 90% confluence, then switched to DMEM supplemented with 4% horse serum for 7 d at 37 C in 5% CO 2 at normoxia (20% O 2 ). Immortalized mouse embryonic fibroblasts (MEFs) were cultured in DMEM with 10% FBS at 37 C in 5% CO 2 at normoxia (20% O 2 ). The following methionine and cysteine deprivation conditions (-M&C) were used to simulate methionine restriction in vitro. For primary EC, when cultures reached confluence, the media was removed and replaced either with complete DMEM ± M&C plus Glutamax (no pyruvate) (Sigma) supplemented with the same amount (2%) of dialyzed FBS and endothelial growth medium SingleQuots (Clonetics, Lonza) for 1 to 24 hr. For hepatocytes, MDFs, primary or C2C12 myotubes and MEF cultures, the media was removed and replaced with complete DMEM ± M&C (plus Glutamax, no pyruvate; Sigma) supplemented with dialyzed FBS (10% for hepatocytes, MDFs and MEFs; 4% for primary skeletal muscle and C2C12 myotubes)
Where indicated, media was supplemented with L-NAME (100 mM), NaHS (100 mM), PAG (100 mM), SU5416 (20 mM), axitinib (10 mM), Ex527 (10 mM), 2-DG (1 mM or 50 mM), Compound C (10 mM) or STO-609 (5 mg/mL). Hypoxia was induced via air displacement with nitrogen gas.
METHOD DETAILS
Intramuscular adenoviral-mediated gene delivery Local overexpression of CGL or VEGF in gastrocnemius was accomplished by intramuscular injection of 40 mL containing a total of 10 9 PFU of an adenovirus-type 5 (dE1/E3) containing the CMV promoter driving expression of the mouse CGL gene (Ad-mCTH/CGL, GenBank RefSeq BC019483, ADV-256305 Vector Biolabs) or the human VEGF gene (Ad-hVEGFA165 GenBank RefSeq NM_001171626, Vector Biolabs) or the negative control virus Ad-CMV Null (1300 Vector Biolabs) once weekly for 2 weeks.
Hindlimb ischemia model 12 week old C57BL/6 WT mice were anaesthetized with isoflurane and body temperature maintained on a circulating heated water pad. Following a 1 cm groin incision, the neurovascular pedicle was visualized under a microscope (LW Scientific, Z2 Zoom Stereoscope) and the femoral nerve carefully dissected out. The femoral vein (located medially) was separated from the femoral artery (located laterally) allowing electrocoagulation of the left common femoral artery, proximal to the bifurcation of superficial and deep femoral artery while sparing the vein and nerve. Once the artery was occluded, the surgical site was inspected for any residual bleeding (Hoefer et al., 2004; Mirabella et al., 2011) .
Laser Doppler perfusion imaging
Laser Doppler perfusion imaging (LDPI) was performed as described previously (Hoefer et al., 2004; Mirabella et al., 2011) . Briefly, mice were kept under isoflurane anesthesia, and body temperature maintained on a circulating heated water pad. Blood flow recovery was monitored at d0 (immediately post-surgery), d1, d3, and d10 using an LDPI analyzer (Moor Instruments, DE). The LDPI intensity of the ischemic foot was normalized to the contralateral foot and represented as relative blood flow of the ischemic limb (Ischemic/Nonischemic ratio). AUCs from I/NI ratios from each animal over time were used for statistical comparisons between groups.
Treadmill exercise training 12 wk old male WT and CGLKO mice were randomized into sedentary or exercise groups. Mice were acclimatized to the treadmill (Columbus Instruments 6 lane treadmill) at 8 m/min for 5 min for 3 d prior to exercise training. Mice ran 30 min/d at 5 incline at 12 m/min for the first wk of training. Mice continued running 30 min/d at 5 incline at 14 m/min for an additional 3 wk to reach 1 mo total of exercise training. Sedentary controls and exercised animals were co-housed. Mice were euthanized 1 hr after the final exercise bout (Narkar et al., 2008) .
Treadmill exercise test 2 and 3 days after ischemic injury, mice were acclimatized to the treadmill (Columbus Instruments 6 lane treadmill) at 8 m/min for 5 min prior to exercise testing. At d4, mice were run until exhaustion at 5 incline, 8 m/min for 10 min then 10 m/min for 5 min, with a 2 m/min increase in speed every 5 min (Narkar et al., 2008) .
Gene expression analysis by qPCR Total RNA was isolated from tissues and cells using RNeasy Mini Kit (QIAGEN) and cDNA synthesized by random hexamer priming with the Verso cDNA kit (Thermo). qRT-PCR was performed with SYBR green dye (Lonza) and TaqPro DNA polymerase (Denville). Fold changes were calculated by the DDC t method (Livak and Schmittgen, 2001 ) using Hprt, 18S and/or b-Actin genes as standards, and normalized to the experimental control. Human primer sequences are indicated in the Key Resources Table, and mouse primer sequences are additionally found in Table S1 .
Immunoblotting Cells were homogenized with passive lysis buffer (Promega), normalized for protein content, boiled with SDS loading buffer and separated by SDS-PAGE. Proteins were transferred to PVDF membrane (Whatman) and blotted for CGL (ab151769 Abcam), HIF1a (10006421 Cayman Chemical), p-eIF2a Ser51 (9712S Cell Signaling), total eIF2a (9722S Cell Signaling), ATF4 (11815 Cell Signaling), Actin (13E5 Cell Signaling) and Tubulin (2146S Cell Signaling) and secondarily with HRP-conjugated anti-rabbit antibody (Dako).
VEGF ELISAs
Mouse and human VEGF ELISA kits were purchased from Peprotech (900-K99) and R&D System (DEV00), respectively, and assays performed according to manufacturer's instructions on 100 mL of plasma or cell culture media per analysis. For analysis of VEGF protein in muscle, approximately 100 mg of frozen gastrocnemius muscle was pulverized using a mortar and pestle, and the powder transferred to a 1.5 mL microcentrifuge tube containing 150 mL of PBS. The tissue was further disrupted using a mechanical tissue homogenizer (Kimble Kontes Pellet Pestle, Fisher Scientific). After three cycles of freezing and thawing, the tissue suspension was microcentrifuged at max speed for 10 min and the supernatant recovered and stored at À80
C. Lysates were adjusted to 0.5 mg/mL in PBS and assayed using a mouse VEGF ELISA kit from R&D systems (MMV00).
Immunohistochemistry and capillary density analysis IHC was performed on frozen sections of unfixed gastrocnemius muscle (50 mm for CD31 quantification; 20 mm for CD31/VEGF/IB4 co-staining). After 5 min fixation in PFA 4% and rinsing in PBS, immunostaining was performed as previously described (Longchamp et al., 2014) . Primary antibodies included anti-mouse CD31 (BD Bioscience), anti-mouse VEGF (Novus Biologicals) and Isolectin B4 (Life Technologies) at a dilution of 1:100. For capillary density measurements, CD31 area was quantified from randomly photographed 10 mm stack sections (6 images per section, 4 sections per muscle per mouse) using Fiji software (http://fiji.sc/Fiji). All quantifications were performed blindly.
CD31 FACS analysis
Following enzymatic digestion of muscle with collagenase/dispase mix, cells were blocked with mouse FcR blocking reagent (Miltenyl Biotech) and stained for 30 min at 4 o C in the dark with CD31APC at 1:100 (BioLegend). Cells were washed and acquired immediately on an LSR II flow cytometer (BD Biosciences) and analyzed with FlowJo. CD31 positive endothelial cells are expressed as a percentage of total cells recovered from the enzymatically digested muscle cells as assessed by forward and side scatter.
H 2 S measurements
Detection of H 2 S production capacity in live cultures by lead sulfide method For detection of H 2 S production in live cells, growth media was supplemented with 10 mM L-cysteine and 10 mM pyridoxal 5 0 -phosphate hydrate (PLP, Sigma), and a 6x4 inch piece of lead acetate paper, made by soaking 703 size blotting paper (VWR) in 20 mM lead acetate (Sigma) and then vacuum dried, was placed over the plate for 2-24 hr of further incubation in a CO 2 incubator at 37 C until lead sulfide was detected but not saturated. Detection of endogenous H 2 S with fluorescent P3 probe in cultured cells or frozen tissue sections For detection of endogenous H 2 S production in live adherent cells, growth media was supplemented with 10 mM P3 probe (Singha et al., 2015) for 30 min prior to fixation. Quantification was performed by calculating the average P3 signal intensity per cell. Cell areas were automatically segmented using brightfield images. Values presented are average P3 intensity per cell, corrected for total cell area. Analyses were performed using MATLAB R2017A.
For detection of endogenous H 2 S production in tissue sections, 50 mm frozen sections of unfixed gastrocnemius muscle were incubated with 20 mM P3 probe for 5 min and washed 2X with PBS. Sections were then fixed for 5 min in 4% PFA prior to immunostaining using a 2 photon microscope (Zeiss LSM780 w/ Mai Tai HP 2-photon laser (Spectra Physics) at 880 nm excitation and 520-550 nm emission (Singha et al., 2015) .
Genetic manipulations in cultured cells
siRNA knockdown siRNA knockdown of human activating transcription factor 4 (ATF4), human endothelial nitric oxide synthase (eNOS), human hypoxia-inducible factor 1a (HIF1a), PGC1a (PPARGC1A) in HUVECs as well as mouse HIF1a and PGC1a in C2C12 myoblasts was performed using lipofectamine RNAiMAX (Life Technologies) and 30 nM siRNA purchased from Ambion (Ambion, ThermoFisher) as described previously (Hine et al., 2015) . All experiments were performed 2 days after transfection. Knockdown was confirmed by immunoblot and/or qPCR. shRNA knockdown of ATF4 MDFs were infected overnight in complete medium and collected 2 days later using Ad-m-ATF4-shRNA or the negative control virus Ad-CMV Null adenovirus amplified and purified by Vector Biolabs (Philadelphia, PA, U.S.A.). ATF4 overexpression ATF4 overexpression in HUVECs was performed using Lipofectamine 2000 (Life Technologies) and 1 mg of prK-ATF4 plasmid per well (12-well format) overnight. All experiments were performed 2 days after transfection. Overexpression was confirmed by immunoblot and/or qPCR. Adenoviral-mediated CGL overexpression HUVECs were infected overnight in complete medium using Ad-m-CTH or the negative control virus Ad-CMV Null adenovirus amplified and purified by Vector Biolabs (Philadelphia, PA, U.S.A.) and collected 2 days later.
Angiogenesis assays in vitro
Migration assay ECs were seeded at 100,000 cells per well in a 24-well plate in EGM with 2% serum and growth factors (Lonza). $12 hr later, media was switched to EGM without serum/growth factors, and in some cases mitotically arrested (1 mg/mL MitoC). A single scratch was created using a sterile p200 pipette tip on a confluent field of EC. Floating cells were washed away and EGM (or DMEM ± M&C media) with dialyzed serum and growth factors replaced, including treatments. Repopulation/migration across the scratch was recorded by phase-contrast microscopy every 4 hr for up to 20 hr using a digital camera. Migration across the scratch (gap area at t = X hr relative to t = 0 hr) was determined at each time point from digital images using ImageJ software. Tube formation Formation of tube networks was assessed as described previously (Borradaile and Pickering, 2009) . HUVECs were seeded at 10,000 cells per well in a 24-well plate (Corning) coated with 150 mL Cultrex reduced growth factor basement membrane extract (Trevigen). Following an 18 hr-incubation, resulting tube networks were analyzed by light microscopy (Nikon Eclipse TiE). The total length of tubule networks and the number of branch points were quantified by ImageJ software. Spheroid capillary sprouting assay Hanging drops of HUVECs or primary mouse ECs in EGM2 (De Bock et al., 2013) were embedded in Matrigelâ (Corning) and cultured in the indicated media for 24 hr to induce sprouting. Compounds were added at the indicated concentrations during the gel culture step, using corresponding vehicle concentrations as control. Spheroid cultures were stained with phalloidin diluted 1:500 in PBST for 1 hr at RT and counterstained with DAPI. Images were captured with a Zeiss LSM 510 Meta NLO confocal microscope (oil objectives: x 40 with NA 1.3, x 63 with NA1.4, x 100 with NA 1.3; Carl Zeiss, Munich, Germany) or a Leica laser-scanning SP5 confocal microscope (Leica, Manheim, Germany). Analysis of the sprout length was performed using ImageJ software.
Proliferation
HUVECs were cultured to 60% confluency in a 12-well plate on glass coverslips, washed with PBS and incubated for 24 hr in EGM2 containing 0.1 mM BrdU. Immunostaining was performed on cells washed and fixed for 5 min in À20 C acetone, air-dried, rinsed in PBS and permeabilized for 1 hr in PBS supplemented with 2% BSA and 0.1% Triton X-100. BrdU positive nuclei were automatically detected using the ImageJ software and normalized to the total number of DAPI-positive nuclei.
Glucose uptake For VEGF and NaHS treatment ± Compound C (10 mM) ( Figures 5D and S6A ), HUVECs were pretreated for 1 hr with 50 ng/ml VEGF (Peprotech) or 100 mM NaHS. Cells were then depleted in Krebs-Ringer Bicarbonate Buffer (KRB; NaH 2 PO 4 /Na 2 HPO 4 10 mM, NaCl 136 mM, KCl 4.7 mM, MgSO4 1.25mM, CaCl2 1.25mM, pH7.4), without glucose and serum for 30 min and then incubated for 6 min in a solution containing 0.5 mCi 3 H-2-DG. On ice, cells were then washed in cold PBS 3 times, lysed, and sample counted in a liquid scintillation counter. Samples were normalized to protein content as measured from the same cells by BCA. For remaining glucose uptake experiments (Figures S5B, S6G, S6I and 6G) , EC were treated with NaHS (100 mM), KCN (10 mM), Antimycin A (2.5 mM), Oligomycin (2 mM), or FCCP (1.5 mM) for 45, 75 or 195 min in EGM-2. When indicated, inhibitors were added 30 min before the addition of the tracer. Fifteen min before the termination of the experiment, 0.4 mCi of 3 H-2-DG was added to each well (1 mL final volume, 12-well format). At the end of the incubation the plate was rapidly transferred on ice, media removed and washed 4 times with PBS + BSA 0.1%. Finally, cell lysis was performed with NaOH 0.2% + SDS 0.5%. Lysate (500 mL) was mixed with scintillation fluid (5 mL) and sample radioactivity measured in a scintillation counter (Beckman).
Glycolytic flux analysis
HUVECs were cultured with standard media (EGM-2), and stimulated for up to 3 hr with test compounds (NaHS 100 mM, VEGF 50ng/mL, Antimycin A 2.5 mM, Oligomycin 2 mM, or 2-DG 1mM). 15 min before the end of the incubation, 5 mCi D-[5-3H(N)]-glucose was added to 1.5 mL media (12-well format), then the plate was rapidly transferred on ice, and the media (1.5 mL) transferred into a 5 mL vial. One PBS wash (1.5 mL) was performed and liquid combined with media. The vial was inserted into a 50 mL tube pre-filled with 3 mL water. The tube was tightly capped and evaporation was performed at room temperature for 48 hr. Finally, 2 mL of water was collected from the 50mL tube and mixed with 10 mL of scintillation fluid. Sample radioactivity was measured in a scintillation counter (Beckman).
ATP and ATP/ADP ratio Cells in a 96-well format were treated with NaHS, VEGF or 2-DG in a reverse time course. ATP was measured by addition of 70 mL of Cell TITER-Glo (Promega), plate incubated in the dark for 10 min and luminescence quantified by a plate reader (BioTek instruments). ADP/ATP ratio was calculated after measuring ADP and ATP by a commercially available enzymatic assay (ApoSENSOR, BioVision), according to the manufacturer's instructions.
Energy charge
Steady-state mass spec measurements of AMP, ADP and ATP were used to calculate energy charge using the following equation: (ATP +1/2ADP)/(ATP + ADP + AMP).
Lactate
Lactate in HUVEC culture media was measured after 1.5-6 hr of treatment with NaHS (100 mM). The assay was performed using a plate-based colorimetric assay (Cell Biolabs) according to the manufacturer's protocol.
Cell death and ROS
Apoptosis and cell death were measured after 12 hr treatment with NaHS (100 mM) or -M&C using a FACS-based annexin V/propidium iodide assay according to the manufacturer's protocol (BD Biosciences).
Reactive oxygen species were measured after 15 min, 1 hr and 2 hr incubations with NaHS (100 mM), FCCP (2 mM) or KCN (10 mM). Menadione (10 mM) was used as a positive control. Cells were stained for 15 min with CellROX Green dye in the treatment media, fixed with 2% paraformaldehyde and measured using FACS.
Seahorse
Cellular oxygen consumption and extracellular acidification rate was measured using the Seahorse Cell Metabolism Analyzer XF96 (Seahorse Biosciences). Cells were plated at a density of 12,000 cells and untreated or pretreated with 100 mM NaHS, 10 mM KCN or 500 mM phenformin for 2 hr. After 2 hr, media was changed to unbuffered XF assay media with 0 or 11 mM glucose, 0 or 2 mM glutamine and pyruvate at pH7.4 and basal OCR and ECAR measured for 5 blocks of 2 min mixing and 5 min measuring. Glucose (10 mM final), 2-DG (50 mM final) and Oligomycin (2.5 mM final) were injected at indicated times. All plates were normalized to protein content as measured from the same cells after Seahorse by BCA.
Mitochondrial respiration in permeabilized cells using complex-specific substrates was measured in a Seahorse Cell Metabolism Analyzer XF24 (Seahorse Biosciences) as previously described (Salabei et al., 2014) . Briefly, cells were plated at a density of 100,000 cells in EGM-2. Four hr later, cells were pretreated with 100 mM NaHS or 10 mM KCN for 1 hr, then washed with MAS buffer and incubated with MAS buffer containing 10 mM pryruvate, 2 mM malate, 4 mM FCCP and 25 mg/mL Saponin for 1 hr. OCR was measured for 10 blocks of 1 min mixing and 2 min measuring. Rotenone (1 mM final), Succinate (10 mM final), Antimycin A (20 mM final), and TMPD/Ascorbate (0.5 mM/2 mM final) were injected in order.
Metabolite profiling for glucose flux analyses
To determine the relative levels of intracellular metabolites, extracts were prepared and analyzed by LC/MS/MS. Triplicate 15-cm confluent plates were incubated in EGM-2 media in presence or absence of 100 mM NaHS 105 min prior to extraction. For D-[1,2-13 C ]-glucose flux studies, cells were washed once with serum-and glucose free DMEM and then incubated in DMEM containing a 10 mM 1:1 mixture of D-[1,2-13 C ]-glucose and unlabeled D-glucose for 15 min. Metabolites were extracted on dry ice with 4 mL 80% methanol (À80 C) as described previously (Ben-Sahra et al., 2013) . Insoluble material was pelleted by centrifugation at 3000g for 5 min, followed by two subsequent extractions of the insoluble pellet with 0.5 mL 80% methanol, with centrifugation at 16,000g for 5 min. The 5 mL metabolite extract from the pooled supernatants was dried down under nitrogen gas using an N-EVAP (Organomation Associates).
Dried pellets were resuspended using 20 mL HPLC grade water for mass spectrometry. 10 mL was injected and analyzed using a 5500 QTRAP triple quadrupole mass spectrometer (AB/SCIEX) coupled to a Prominence UFLC HPLC system (Shimadzu) via selected reaction monitoring (SRM). Some metabolites were targeted in both positive and negative ion mode for a total of 287 SRM transitions using pos/neg polarity switching. ESI voltage was +4900V in positive ion mode and -4500V in negative ion mode. The dwell time was 3 ms per SRM transition and the total cycle time was 1.55 s. Approximately 10-14 data points were acquired per detected metabolite. Samples were delivered to the MS via normal phase chromatography using a 4.6 mm i.d. x 10 cm Amide Xbridge HILIC column (Waters) at 350 mL/min. Gradients were run starting from 85% buffer B (HPLC grade acetonitrile) to 42% B from 0-5 min; 42% B to 0% B from 5-16 min; 0% B was held from 16-24 min; 0% B to 85% B from 24-25 min; 85% B was held for 7 min to re-equilibrate the column. Buffer A was comprised of 20 mM ammonium hydroxide/20 mM ammonium acetate (pH = 9.0) in 95:5 water:acetonitrile. Peak areas from the total ion current for each metabolite SRM transition were integrated using MultiQuant v2.0 software (AB/SCIEX). For stable isotope labeling experiments, custom SRMs were created for expected 13 C incorporation in various forms for targeted LC/MS/MS. Samples were quantile normalized and log transformed and metabolites were pareto scaled prior to analysis. Analyses were performed using R version 3.3.2.
Global metabolite profiling
HUVECs grown in EBM-2 media with BulletKit were switched to DMEM with 2% dialyzed FBS and all non-serum BulletKit components. After a 1 hr equilibration period, cells were switched to treatment media (control, -M&C, NaHS 100 mM). After the treatment period (15 min, 2 hr, 4 hr) cells were collected and analyzed for total metabolite profile by mass spectrometry using the methods detailed in the preceding section.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are displayed as means ± standard deviation (SD) and statistical significance assessed in GraphPad Prism using Student's t test, one-way or two-way ANOVA unless otherwise specified. A P value of 0.05 or less was deemed statistically significant. Figure S1 . SAA Restriction Induces Endothelial VEGF Expression In Vitro and Functional Angiogenesis In Vivo, Related to Figure 1 
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